Skip to main content
Toggle navigation
Login
Search
Home
Tweets by SSO 2024 Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded for On-Demand Viewing
Back
Tweet
Industry Forum Breakfast: Merck: An Adjuvant Treatment Option for Certain Patients with Melanoma after Complete Resection
Thursday, March 21, 2024
7:00am – 8:00am
ET
Location: C109
Industry Presenter(s)
CB
Chandar Bhimani, MD
Learning Objectives:
Understand the recurrence rates in resected stage IIB, IIC, and III melanoma observed in retrospective studies;
Review clinical data supporting an adjuvant treatment option for certain patients with completely resected melanoma;
Review safety data for this adjuvant treatment option.
